三辨治癌合并介入治疗中晚期胃癌43例
|
摘要
目的:观察三辨治癌指导下参藤消胃积汤配合介入治疗中晚期胃癌的临床疗效。方法:口服参藤消胃积汤,每日1剂;同时配合介入,治疗中晚期胃癌。结果:CR+PR+NC=95.3%,中位生存期23个月,;1年生存率76.7%,2年生存率44.1%,3年生存率27.8%,4年生存率16.3%,5年生存率7.0%。结论:根据"三辨论治"即辨证论治、辨病理论治、辨病位论治,参藤消胃积汤配合介入治疗胃癌,能显著提高患者的生存质量及生存期,疗效显著。
Objective: To evaluate the clinical therapeutic effect of henteng Xiaoweiji Decoction with the interventional therapy on advanced gastric cancer under the guidance of cancer treatment based on SPL theory. Methods: Oral Shen Teng Xiaoji medicinal broth,a dose of medicine everyday,it cures advanced gastric cancer cooperating interventional therapy. Results: The effective rate of tumor changes was 95. 3% and the effective rate of quality of life was 97. 7%. MST was 23 months and one-year survival rate was 76. 7%,two-year survival rate 44. 1%,three-year survival rate 27. 8%,four-year survival rate 16. 3%,five-year survival rate 7. 0%. Conclusion: According to the cancer treatment based on SPL theory,which contains differentiation of symptoms and signs,differentiation of pathological changes and differentiation of disease locations,Shenteng Xiaoweiji Decoction with interventional therapy can significantly improve the survival quality of the advanced gastric cancer patients and extend their life span.
Objective: To evaluate the clinical therapeutic effect of henteng Xiaoweiji Decoction with the interventional therapy on advanced gastric cancer under the guidance of cancer treatment based on SPL theory. Methods: Oral Shen Teng Xiaoji medicinal broth,a dose of medicine everyday,it cures advanced gastric cancer cooperating interventional therapy. Results: The effective rate of tumor changes was 95. 3% and the effective rate of quality of life was 97. 7%. MST was 23 months and one-year survival rate was 76. 7%,two-year survival rate 44. 1%,three-year survival rate 27. 8%,four-year survival rate 16. 3%,five-year survival rate 7. 0%. Conclusion: According to the cancer treatment based on SPL theory,which contains differentiation of symptoms and signs,differentiation of pathological changes and differentiation of disease locations,Shenteng Xiaoweiji Decoction with interventional therapy can significantly improve the survival quality of the advanced gastric cancer patients and extend their life span.
引文
[1]张士舜.三辨治癌[G].国际传统医药大会论文摘要汇编,北京,2000.
[2]张士舜.一种用于晚期胃癌的药物组合物:中国,2009100755458[P].2009-09-25.
[3]孙燕.内科肿瘤学[M].北京:人民卫生出版社,1991:87.
[4]张健.生活质量研究与恶性肿瘤的中医疗效评价[J].北京中医药大学学报,2000,23(2):67-69.
[5]樊翠珍,初玉平,戴红.卡培他滨联合奥沙利铂与替吉奥联合奥沙利铂治疗进展期胃癌的对比研究[J].临床肿瘤学杂志,2011,16(8):725-727.
[6]周平,郑圣齐.羟基喜树碱、奥沙利铂和卡培他滨联合治疗晚期胃癌的临床观察[J].临床肿瘤学杂志,2011,16(8):739-741.
[2]张士舜.一种用于晚期胃癌的药物组合物:中国,2009100755458[P].2009-09-25.
[3]孙燕.内科肿瘤学[M].北京:人民卫生出版社,1991:87.
[4]张健.生活质量研究与恶性肿瘤的中医疗效评价[J].北京中医药大学学报,2000,23(2):67-69.
[5]樊翠珍,初玉平,戴红.卡培他滨联合奥沙利铂与替吉奥联合奥沙利铂治疗进展期胃癌的对比研究[J].临床肿瘤学杂志,2011,16(8):725-727.
[6]周平,郑圣齐.羟基喜树碱、奥沙利铂和卡培他滨联合治疗晚期胃癌的临床观察[J].临床肿瘤学杂志,2011,16(8):739-741.